The global angiographic catheters market size was estimated at USD 1.61 billion in 2025 and is projected to reach USD 2.89 billion by 2033, growing at a CAGR of 7.71% from 2026 to 2033. The market growth is driven by the rising incidence of cardiovascular and peripheral vascular diseases, as well as the increasing reliance on image-guided diagnostic and interventional procedures.
The growing prevalence of coronary artery disease, cerebrovascular events, and peripheral artery disease is significantly increasing pressure on healthcare systems worldwide. Angiographic catheters play a key role in enabling precise vascular imaging, controlled contrast injection, and real-time procedural navigation. Healthcare providers are increasingly favoring minimally invasive diagnostic approaches and catheter-based interventions; consequently, the demand for angiographic catheters continues to rise across coronary, neurovascular, and peripheral endovascular procedures.
Within this broader landscape, the hydrophilic angiographic catheters market is gaining traction, driven by the need for enhanced catheter trackability, reduced friction, and improved navigation through tortuous vascular anatomy. Hydrophilic-coated catheters are increasingly preferred in complex diagnostic and interventional procedures, as they support smoother advancement, reduce procedural time, and lower the risk of vascular trauma.
The increasing prevalence of cardiovascular diseases (CVDs) remains a primary factor driving the growth of the angiographic catheters industry. According to Oxford Academic (January 2025), the global age-standardized prevalence of CVD is estimated at approximately 7,179 cases per 100,000 population, highlighting the persistent global burden of heart-related disorders. In the U.S., the prevalence of CVDs, including heart failure and cardiac arrhythmias, continues to rise, largely due to sedentary lifestyles, obesity, and associated metabolic comorbidities.
As clinicians seek earlier diagnosis and safer, minimally invasive interventions, hydrophilic angiographic catheters are increasingly adopted in both coronary and peripheral angiography. Their lubricious surface facilitates smoother vessel access and catheter manipulation, supporting higher procedural success rates in patients with complex vascular disease.
Moreover, as reported by the American Heart Association (AHA) in January 2025, in the U.S., cardiovascular disease remains a significant public health challenge, with one death occurring approximately every 34 seconds, amounting to nearly 2,500 deaths each day. This high mortality burden highlights the urgent need for timely diagnosis and effective management of vascular conditions such as coronary artery disease and stroke. Angiographic catheters are integral to this effort, as they enable detailed visualization of blood vessels, accurate contrast delivery, and real-time guidance during both diagnostic angiography and interventional procedures. Clinicians seek to detect arterial blockages earlier and intervene using minimally invasive, catheter-based techniques. Still, the persistent and widespread impact of cardiovascular disease continues to drive the clinical reliance on angiographic catheters.
This product will be delivered within 1-3 business days.
The growing prevalence of coronary artery disease, cerebrovascular events, and peripheral artery disease is significantly increasing pressure on healthcare systems worldwide. Angiographic catheters play a key role in enabling precise vascular imaging, controlled contrast injection, and real-time procedural navigation. Healthcare providers are increasingly favoring minimally invasive diagnostic approaches and catheter-based interventions; consequently, the demand for angiographic catheters continues to rise across coronary, neurovascular, and peripheral endovascular procedures.
Within this broader landscape, the hydrophilic angiographic catheters market is gaining traction, driven by the need for enhanced catheter trackability, reduced friction, and improved navigation through tortuous vascular anatomy. Hydrophilic-coated catheters are increasingly preferred in complex diagnostic and interventional procedures, as they support smoother advancement, reduce procedural time, and lower the risk of vascular trauma.
The increasing prevalence of cardiovascular diseases (CVDs) remains a primary factor driving the growth of the angiographic catheters industry. According to Oxford Academic (January 2025), the global age-standardized prevalence of CVD is estimated at approximately 7,179 cases per 100,000 population, highlighting the persistent global burden of heart-related disorders. In the U.S., the prevalence of CVDs, including heart failure and cardiac arrhythmias, continues to rise, largely due to sedentary lifestyles, obesity, and associated metabolic comorbidities.
As clinicians seek earlier diagnosis and safer, minimally invasive interventions, hydrophilic angiographic catheters are increasingly adopted in both coronary and peripheral angiography. Their lubricious surface facilitates smoother vessel access and catheter manipulation, supporting higher procedural success rates in patients with complex vascular disease.
Moreover, as reported by the American Heart Association (AHA) in January 2025, in the U.S., cardiovascular disease remains a significant public health challenge, with one death occurring approximately every 34 seconds, amounting to nearly 2,500 deaths each day. This high mortality burden highlights the urgent need for timely diagnosis and effective management of vascular conditions such as coronary artery disease and stroke. Angiographic catheters are integral to this effort, as they enable detailed visualization of blood vessels, accurate contrast delivery, and real-time guidance during both diagnostic angiography and interventional procedures. Clinicians seek to detect arterial blockages earlier and intervene using minimally invasive, catheter-based techniques. Still, the persistent and widespread impact of cardiovascular disease continues to drive the clinical reliance on angiographic catheters.
Global Angiographic Catheters Market Report Segmentation
This report forecasts volume & revenue growth at the global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global angiographic catheters market report based on product type, application, material, end use, and region:- Product Type Outlook (Unit Volume in ‘000 Units; Revenue in USD Million, 2021-2033)
- Diagnostic Catheters
- Interventional Catheters
Application Outlook (Revenue, USD Million, 2021-2033)
- Coronary
- Endovascular
- Neurology
- Oncology
Material Outlook (Revenue, USD Million, 2021-2033)
- Nylon
- Polyurethane
- PEBAX (Polyether block amide)
- Silicone
End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Others
- Regional Outlook (Unit Volume in ‘000 Units; Revenue in USD Million, 2021-2033)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology And Scope
Chapter 2. Angiographic Catheters Market: Executive Summary
Chapter 3. Angiographic Catheters Market Variables, Trends, & Scope
Chapter 4. Angiographic Catheters Market Segment Analysis, By Product Type (Revenue in USD Million; Unit Volume in ‘000 Units; 2021-2033)
Chapter 5. Angiographic Catheters Market Segment Analysis, By Application 2021 2033 (USD Million)
Chapter 6. Angiographic Catheters Market Segment Analysis, By Material 2021 2033 (USD Million)
Chapter 7. Angiographic Catheters Market Segment Analysis, By End Use 2021 2033 (USD Million)
Chapter 8. Angiographic Catheters Market Segment Analysis, By Region, (Revenue in USD Million; Unit Volume in ‘000 Units; 2021-2033)
Chapter 9. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this Angiographic Catheters market report include:- Boston Scientific Corp.
- Medtronic plc
- Terumo Medical Corporation
- Merit Medical System Inc
- B. Braun SE
- MicroPort Scientific Corp.
- Lepu Medical Technology (Beijing) Co Ltd
- Angiodynamics Inc
- Cook Medical
- Cordis
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 1.61 Billion |
| Forecasted Market Value ( USD | $ 2.89 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
